Skip to main content

Leukemia

Leukemia, Oncology
Researchers Identify First Mutation to Explain Resistance to Venetoclax
Phoebe Starr
Phoebe Starr
Read More
Leukemia, Oncology
MURANO: Venetoclax-Rituximab at Fixed Duration Beats Chemo­immunotherapy in Relapsed/Refractory CLL
Phoebe Starr
Phoebe Starr
Read More
Leukemia, Oncology
Next-Generation Sequencing Could Help Treatment Decisions in Acute Myeloid Leukemia
Chase Doyle
Read More
Leukemia, Oncology
Nelarabine Therapy Up Front Boosts Survival in T-Cell Leukemia and Lymphoma
Phoebe Starr
Read More
Leukemia, Oncology
ASCO 2017: Acute Myeloid Leukemia Highlights
Read More
Leukemia, Oncology
In Chronic Myeloid Leukemia, Selection of Tyrosine Kinase Inhibitors Depends on Variables Other Than Survival
Wayne Kuznar
Read More
Leukemia, Oncology
ASCO 2017: Chronic Lymphocytic Leukemia Highlights
Read More
Leukemia, Oncology
American Society of Hematology 2016: Leukemia Highlights
Read More
Leukemia, Oncology
Lenalidomide Maintenance Therapy Extends Progression-Free Survival in Patients with High-Risk Chronic Lymphocytic Leukemia
Wayne Kuznar
Read More
Leukemia, Oncology
Ponatinib, a Tyrosine Kinase Inhibitor, Active in Patients with Relapsed or Refractory Chronic Myeloid Leukemia and BCR-ABL T315I Mutation
Charles Bankhead
Read More
Page 3 of 7
Results 21 - 30 of 70